Assignee
ENTERA BIO LTD
IL·7 granted patents·8 pending applications·25 citations·filing 2015–2025
Top patents by PatentIndex Score
15 records- 0193US10010503B2Methods and compositions for oral administrationENTERA BIO LTD·Filed 2015·Granted Jul 3, 2018·11 cites·24 claims
- 0290US10420721B2Methods and compositions for oral administrationENTERA BIO LTD·Filed 2018·Granted Sep 24, 2019·6 cites·16 claims
- 0386US11246827B2Methods and compositions for oral administrationENTERA BIO LTD·Filed 2019·Granted Feb 15, 2022·1 cites·16 claims
- 0485US10583177B2Formulations for oral administration of active agentsENTERA BIO LTD·Filed 2016·Granted Mar 10, 2020·5 cites·23 claims
- 0583US2025281396A1Methods and compositions for oral administrationENTERA BIO LTD·Filed 2025·Application pending·0 cites
- 0682US12076373B2Formulations for oral administration of active agentsENTERA BIO LTD·Filed 2019·Granted Sep 3, 2024·2 cites·18 claims
- 0780US12311051B2Methods and compositions for oral administrationENTERA BIO LTD·Filed 2022·Granted May 27, 2025·0 cites·16 claims
- 0877US2024398904A1Formulations for oral administration of active agentsENTERA BIO LTD·Filed 2024·Application pending·0 cites
- 0975US2024181020A1Treatment of hypoparathyroidismENTERA BIO LTD·Filed 2024·Application pending·0 cites
- 1069US2024415936A1Formulations for oral administration of active agentsENTERA BIO LTD·Filed 2024·Application pending·0 cites
- 1156US2025186558A1Formulations comprising acid-neutralizing polymer for oral administration of active agentsENTERA BIO LTD·Filed 2023·Application pending·0 cites
- 1256US2025186559A1Formulations comprising acid-neutralizing polymer for oral administration of parathyroid hormoneENTERA BIO LTD·Filed 2023·Application pending·0 cites
- 1356US2025186555A1Formulations comprising acid-neutralizing polymer for oral administration of glucagon-like peptide-2ENTERA BIO LTD·Filed 2023·Application pending·0 cites
- 1456US2025186554A1Formulations comprising acid-neutralizing polymer for oral administration of glucagon-like peptide-1 and analogs thereofENTERA BIO LTD·Filed 2023·Application pending·0 cites
- 1552US12239691B2Formulations for oral administration of active agentsENTERA BIO LTD·Filed 2017·Granted Mar 4, 2025·0 cites·30 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →